Clinical Trials Directory

Trials / Completed

CompletedNCT03899896

Voice Feminisation in Transgender Women

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The voice is a reflection of our identity. In the case of transgender women, there may be a gap between perceived male voice and female appearance. Indeed, hormonal treatment in transgender women has no effect on the voice quality. This gap can have negative consequences on everyday life in banal situations such as telephonic contact leading to limited use of phone calls and social isolation. Differences between female and male voices seem to be socially determined and do not depend directly on sexual dimorphism of the phonatory organs. Speech therapy might thus be indicated as a vocal support for transgender women. Only few studies have examined the impact of perceived voice on the quality of life of transgender women.

Conditions

Timeline

Start date
2019-02-28
Primary completion
2020-03-05
Completion
2020-03-05
First posted
2019-04-02
Last updated
2022-07-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03899896. Inclusion in this directory is not an endorsement.